Old Web
English
Sign In
Acemap
>
Paper
>
Trastuzumab Therapy for 9 Weeks vs 1 Year for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Trastuzumab Therapy for 9 Weeks vs 1 Year for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
2019
Zachary R. McCaw
Fei Jiang
L. J. Wei
Keywords:
Breast cancer
Trastuzumab
Oncology
Internal medicine
Human Epidermal Growth Factor Receptor 2
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
6
References
2
Citations
NaN
KQI
[]